Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology. It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful. Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.
Artificial intelligence is transforming dermatology by augmenting patient communication, diagnostic precision, and administrative efficiency. Research indicates that patients frequently rate AI-generated responses to clinical questions as superior in quality and empathy compared to human counterparts, although a prefer...
Dermatology literature reveals critical diagnostic and therapeutic insights for complex skin conditions. Demodicosis in hematopoietic stem cell transplant patients often mimics acute graft-versus-host disease, necessitating careful evaluation to avoid misdiagnosis, while ivermectin treatment may trigger systemic Mazzot...
Clinical advancements in dermatology center on the efficacy and safety of new systemic therapies and the management of complex comorbidities. Duroxolitinib demonstrates significant hair regrowth in alopecia areata, though its use requires careful monitoring for thromboembolic events and mandatory CYP2C9 genotyping. Hid...
Dermatology research and clinical applications take center stage as the hosts evaluate recent studies on pediatric growth, inflammatory skin conditions, and novel therapeutic interventions. Isotretinoin treatment shows no significant impact on final adult height despite temporary velocity dips, while Dupilumab appears ...
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.
